Continuous monitoring of cerebral substrate delivery and clearance: Initial experience in 24 patients with severe acute brain injuries

Alois Zauner, Egon M R Doppenberg, John J. Woodward, Sung C. Choi, Harold F. Young, Ross Bullock

Research output: Contribution to journalArticle

186 Citations (Scopus)

Abstract

OBJECTIVE: Current neuromonitoring techniques in severe human head injury often fail to detect the causes of clinical deterioration. A sensor is now available for continuous monitoring of brain oxygen tension, carbon dioxide tension, and pH values. In this study, brain tissue oxygen tension was used to differentiate patients at risk for brain ischemia and to predict outcome. METHODS: The multiparameter sensor was inserted into brain tissue, along with a standard ventriculostomy catheter and a microdialysis probe, in 24 patients. Lactate and glucose were measured by high-pressure liquid chromatography in hourly dialysate samples. RESULTS: Patients who experienced a good recovery (n = 8) sustained a mean brain partial oxygen pressure of 39 ± 4 mm Hg, brain partial carbon dioxide pressure (PCO2) of 50 ± 8 mm Hg, and a brain pH of 7.14 ± 0.12. Patients with moderate to severe disability (n = 6) sustained a mean brain partial oxygen pressure of 31 ± 5 mm Hg, brain PCO2 of 47 ± 2 mm Hg, and a brain pH of 7.11 ± 0.12. Ten patients who died or remained vegetative sustained a mean brain partial oxygen pressure of 19 ± 8 mm Hg, a brain PCO2 of 64±21 mm Hg, and a brain pH of 6.85 ± 0.41. Mean brain PCO2 levels of 90 to 150 mm Hg were consistently observed after cerebral circulatory arrest or brain death. Dialysate lactate and glucose were less clearly correlated to outcome than brain oxygen tension. Dialysate glucose was extremely low in all patients and zero in most patients who died. CONCLUSION: Brain oxygen pressure, brain carbon dioxide pressure, and brain pH measurements, as well as a microdialysis probe for glucose and lactate analysis, may optimize the management of comatose neurosurgical patients by allowing a fuller understanding of the dynamic factors affecting brain metabolism.

Original languageEnglish
Pages (from-to)1082-1093
Number of pages12
JournalNeurosurgery
Volume41
Issue number5
DOIs
StatePublished - Nov 1 1997
Externally publishedYes

Fingerprint

Brain Injuries
Brain
Oxygen
Partial Pressure
Dialysis Solutions
Carbon Dioxide
Glucose
Lactic Acid
Microdialysis
Pressure
Ventriculostomy
Brain Death
Coma
Brain Ischemia
Craniocerebral Trauma

Keywords

  • Brain carbon dioxide pressure
  • Brain glucose
  • Brain oxygen pressure
  • Brain pH
  • Cerebral blood flow
  • Continuous monitoring
  • Grain lactate

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Continuous monitoring of cerebral substrate delivery and clearance : Initial experience in 24 patients with severe acute brain injuries. / Zauner, Alois; Doppenberg, Egon M R; Woodward, John J.; Choi, Sung C.; Young, Harold F.; Bullock, Ross.

In: Neurosurgery, Vol. 41, No. 5, 01.11.1997, p. 1082-1093.

Research output: Contribution to journalArticle

Zauner, Alois ; Doppenberg, Egon M R ; Woodward, John J. ; Choi, Sung C. ; Young, Harold F. ; Bullock, Ross. / Continuous monitoring of cerebral substrate delivery and clearance : Initial experience in 24 patients with severe acute brain injuries. In: Neurosurgery. 1997 ; Vol. 41, No. 5. pp. 1082-1093.
@article{d283d290a2844922a8d75a43f92190dd,
title = "Continuous monitoring of cerebral substrate delivery and clearance: Initial experience in 24 patients with severe acute brain injuries",
abstract = "OBJECTIVE: Current neuromonitoring techniques in severe human head injury often fail to detect the causes of clinical deterioration. A sensor is now available for continuous monitoring of brain oxygen tension, carbon dioxide tension, and pH values. In this study, brain tissue oxygen tension was used to differentiate patients at risk for brain ischemia and to predict outcome. METHODS: The multiparameter sensor was inserted into brain tissue, along with a standard ventriculostomy catheter and a microdialysis probe, in 24 patients. Lactate and glucose were measured by high-pressure liquid chromatography in hourly dialysate samples. RESULTS: Patients who experienced a good recovery (n = 8) sustained a mean brain partial oxygen pressure of 39 ± 4 mm Hg, brain partial carbon dioxide pressure (PCO2) of 50 ± 8 mm Hg, and a brain pH of 7.14 ± 0.12. Patients with moderate to severe disability (n = 6) sustained a mean brain partial oxygen pressure of 31 ± 5 mm Hg, brain PCO2 of 47 ± 2 mm Hg, and a brain pH of 7.11 ± 0.12. Ten patients who died or remained vegetative sustained a mean brain partial oxygen pressure of 19 ± 8 mm Hg, a brain PCO2 of 64±21 mm Hg, and a brain pH of 6.85 ± 0.41. Mean brain PCO2 levels of 90 to 150 mm Hg were consistently observed after cerebral circulatory arrest or brain death. Dialysate lactate and glucose were less clearly correlated to outcome than brain oxygen tension. Dialysate glucose was extremely low in all patients and zero in most patients who died. CONCLUSION: Brain oxygen pressure, brain carbon dioxide pressure, and brain pH measurements, as well as a microdialysis probe for glucose and lactate analysis, may optimize the management of comatose neurosurgical patients by allowing a fuller understanding of the dynamic factors affecting brain metabolism.",
keywords = "Brain carbon dioxide pressure, Brain glucose, Brain oxygen pressure, Brain pH, Cerebral blood flow, Continuous monitoring, Grain lactate",
author = "Alois Zauner and Doppenberg, {Egon M R} and Woodward, {John J.} and Choi, {Sung C.} and Young, {Harold F.} and Ross Bullock",
year = "1997",
month = "11",
day = "1",
doi = "10.1097/00006123-199711000-00011",
language = "English",
volume = "41",
pages = "1082--1093",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Continuous monitoring of cerebral substrate delivery and clearance

T2 - Initial experience in 24 patients with severe acute brain injuries

AU - Zauner, Alois

AU - Doppenberg, Egon M R

AU - Woodward, John J.

AU - Choi, Sung C.

AU - Young, Harold F.

AU - Bullock, Ross

PY - 1997/11/1

Y1 - 1997/11/1

N2 - OBJECTIVE: Current neuromonitoring techniques in severe human head injury often fail to detect the causes of clinical deterioration. A sensor is now available for continuous monitoring of brain oxygen tension, carbon dioxide tension, and pH values. In this study, brain tissue oxygen tension was used to differentiate patients at risk for brain ischemia and to predict outcome. METHODS: The multiparameter sensor was inserted into brain tissue, along with a standard ventriculostomy catheter and a microdialysis probe, in 24 patients. Lactate and glucose were measured by high-pressure liquid chromatography in hourly dialysate samples. RESULTS: Patients who experienced a good recovery (n = 8) sustained a mean brain partial oxygen pressure of 39 ± 4 mm Hg, brain partial carbon dioxide pressure (PCO2) of 50 ± 8 mm Hg, and a brain pH of 7.14 ± 0.12. Patients with moderate to severe disability (n = 6) sustained a mean brain partial oxygen pressure of 31 ± 5 mm Hg, brain PCO2 of 47 ± 2 mm Hg, and a brain pH of 7.11 ± 0.12. Ten patients who died or remained vegetative sustained a mean brain partial oxygen pressure of 19 ± 8 mm Hg, a brain PCO2 of 64±21 mm Hg, and a brain pH of 6.85 ± 0.41. Mean brain PCO2 levels of 90 to 150 mm Hg were consistently observed after cerebral circulatory arrest or brain death. Dialysate lactate and glucose were less clearly correlated to outcome than brain oxygen tension. Dialysate glucose was extremely low in all patients and zero in most patients who died. CONCLUSION: Brain oxygen pressure, brain carbon dioxide pressure, and brain pH measurements, as well as a microdialysis probe for glucose and lactate analysis, may optimize the management of comatose neurosurgical patients by allowing a fuller understanding of the dynamic factors affecting brain metabolism.

AB - OBJECTIVE: Current neuromonitoring techniques in severe human head injury often fail to detect the causes of clinical deterioration. A sensor is now available for continuous monitoring of brain oxygen tension, carbon dioxide tension, and pH values. In this study, brain tissue oxygen tension was used to differentiate patients at risk for brain ischemia and to predict outcome. METHODS: The multiparameter sensor was inserted into brain tissue, along with a standard ventriculostomy catheter and a microdialysis probe, in 24 patients. Lactate and glucose were measured by high-pressure liquid chromatography in hourly dialysate samples. RESULTS: Patients who experienced a good recovery (n = 8) sustained a mean brain partial oxygen pressure of 39 ± 4 mm Hg, brain partial carbon dioxide pressure (PCO2) of 50 ± 8 mm Hg, and a brain pH of 7.14 ± 0.12. Patients with moderate to severe disability (n = 6) sustained a mean brain partial oxygen pressure of 31 ± 5 mm Hg, brain PCO2 of 47 ± 2 mm Hg, and a brain pH of 7.11 ± 0.12. Ten patients who died or remained vegetative sustained a mean brain partial oxygen pressure of 19 ± 8 mm Hg, a brain PCO2 of 64±21 mm Hg, and a brain pH of 6.85 ± 0.41. Mean brain PCO2 levels of 90 to 150 mm Hg were consistently observed after cerebral circulatory arrest or brain death. Dialysate lactate and glucose were less clearly correlated to outcome than brain oxygen tension. Dialysate glucose was extremely low in all patients and zero in most patients who died. CONCLUSION: Brain oxygen pressure, brain carbon dioxide pressure, and brain pH measurements, as well as a microdialysis probe for glucose and lactate analysis, may optimize the management of comatose neurosurgical patients by allowing a fuller understanding of the dynamic factors affecting brain metabolism.

KW - Brain carbon dioxide pressure

KW - Brain glucose

KW - Brain oxygen pressure

KW - Brain pH

KW - Cerebral blood flow

KW - Continuous monitoring

KW - Grain lactate

UR - http://www.scopus.com/inward/record.url?scp=0030707834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030707834&partnerID=8YFLogxK

U2 - 10.1097/00006123-199711000-00011

DO - 10.1097/00006123-199711000-00011

M3 - Article

C2 - 9361062

AN - SCOPUS:0030707834

VL - 41

SP - 1082

EP - 1093

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 5

ER -